Salivary levels of BAFF, TWEAK, and soluble CD163 and salivary arginase activity before and after periodontal treatment.

OBJECTIVE To monitor salivary B-cell activating factor (BAFF), tumor necrosis factor-like weak inducer of apoptosis (TWEAK), and soluble (s)CD163 levels and arginase activity in periodontitis patients following nonsurgical periodontal treatment. BACKGROUND BAFF, TWEAK, and sCD163 and arginase are associated with activities of B cells and macrophages, which are important regulators of periodontal immune-inflammatory response and healing following treatment. Increased salivary BAFF and sCD163 levels and arginase activity in periodontitis have been demonstrated, but their changes following treatment have not been evaluated before. MATERIALS AND METHODS Forty-four Stage III/IV periodontitis patients and 35 periodontally healthy controls were included in the study. Full-mouth periodontal measurements were recorded and unstimulated saliva was obtained from all participants at baseline. Sample collection and measurements were repeated in periodontitis patients at 2, 6, 12, and 24 weeks following full-mouth scaling and root debridement, whereas controls were only seen at baseline. BAFF, TWEAK, and sCD163 levels were analyzed with bead-based multiplexed immunoassay. Arginase activity was measured with Chinard's method. RESULTS BAFF (p < .001) and sCD163 (p = .003) levels and arginase activity (p < .015) were higher in periodontitis patients compared to healthy controls. BAFF levels (p < .001) and arginase activity (p < .001) of periodontitis patients were reduced at 2 weeks posttreatment and continued to decrease up to 6 (p = .038) and 12 weeks (p = .024), respectively. The reduction of sCD163 levels became significant (p = .003) at 24 weeks posttreatment. CONCLUSIONS The decrease in salivary BAFF levels 2 weeks after periodontal treatment indicates a change in cell signaling toward limited B-cell activation. Decreasing arginase activity similarly reflects a significant reduction in inflammatory response. The reduction in sCD163 levels that are observed at 24 weeks may reflect a longstanding anti-inflammatory macrophage activation, given their multiple functions in immune response, inflammation, and healing.

[1]  E. Fıratlı,et al.  Baseline interleukin‐10, CD163, and tumor necrosis factor‐like weak inducer of apoptosis (TWEAK) gingival tissue levels in relation to clinical periodontal treatment outcomes: A 12‐week follow‐up study , 2022, Journal of periodontology.

[2]  A. Kantarcı,et al.  Molecular biomarker research in periodontology: A roadmap for translation of science to clinical assay validation , 2022, Journal of clinical periodontology.

[3]  Ying Sun,et al.  Endotoxin tolerance induced by Porphyromonas gingivalis lipopolysaccharide alters macrophage polarization. , 2022, Microbial pathogenesis.

[4]  E. Karabulut,et al.  Evaluation of GCF IL-17, IL-10, TWEAK and sclerostin levels after SRP and adjunctive use of diode laser application in periodontitis patients. , 2021, The Journal of Periodontology.

[5]  Ryutaro Kuraji,et al.  Wound healing in periodontal disease induces macrophage polarization characterized by different arginine-metabolizing enzymes. , 2021, Journal of periodontal research.

[6]  C. Kelly,et al.  The TWEAK/Fn14/CD163 axis—implications for metabolic disease , 2021, Reviews in Endocrine and Metabolic Disorders.

[7]  Z. Wang,et al.  B cell activating factor regulates periodontitis development by suppressing inflammatory responses in macrophages , 2021, BMC oral health.

[8]  C. Zheng,et al.  Intersection between macrophages and periodontal pathogens in periodontitis , 2021, Journal of leukocyte biology.

[9]  Anna Lundmark,et al.  Intra-individual cytokine profile in peri-implantitis and periodontitis: a cross-sectional study. , 2021, Clinical oral implants research.

[10]  H. Møller,et al.  Macrophage activity is associated with gingival inflammation: Soluble CD163 in an experimental gingivitis study. , 2020, Cytokine.

[11]  C. Ulecia-Morón,et al.  CD163 overexpression using a macrophage-directed gene therapy approach improves wound healing in ex vivo and in vivo human skin models. , 2019, Immunobiology.

[12]  R. Kotov,et al.  The short-term reliability and long-term stability of salivary immune markers , 2019, Brain, Behavior, and Immunity.

[13]  T. Sobrino,et al.  Severe periodontitis is linked with increased peripheral levels of sTWEAK and PTX3 in chronic migraineurs , 2019, Clinical Oral Investigations.

[14]  Anirudh B Acharya,et al.  Serum sTWEAK levels in chronic periodontitis and type 2 diabetes mellitus. , 2019, Diabetes & metabolic syndrome.

[15]  T. Sobrino,et al.  Periodontitis is associated with systemic inflammation and vascular endothelial dysfunction in patients with lacunar infarct. , 2018, Journal of periodontology.

[16]  E. Karabulut,et al.  Evaluation of gingival crevicular fluid and peri‐implant crevicular fluid levels of sclerostin, TWEAK, RANKL and OPG , 2019, Cytokine.

[17]  G. K. Johnson,et al.  Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. , 2018, Journal of periodontology.

[18]  P. Papapanou,et al.  Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. , 2018, Journal of periodontology.

[19]  R. Caldwell,et al.  Arginase: A Multifaceted Enzyme Important in Health and Disease. , 2018, Physiological reviews.

[20]  Ş. Kurgan,et al.  Molecular basis for immunohistochemical and inflammatory changes during progression of gingivitis to periodontitis , 2018, Periodontology 2000.

[21]  P. Papapanou,et al.  Increased levels of soluble CD163 in periodontitis patients , 2017, Journal of clinical periodontology.

[22]  D. Xuan,et al.  Enhanced Activity of the Macrophage M1/M2 Phenotypes and Phenotypic Switch to M1 in Periodontal Infection. , 2016, Journal of periodontology.

[23]  F. Yoshimura,et al.  Human Memory B Cells in Healthy Gingiva, Gingivitis, and Periodontitis , 2016, The Journal of Immunology.

[24]  T. Sorsa,et al.  Analysis of matrix metalloproteinases, especially MMP-8, in gingival creviclular fluid, mouthrinse and saliva for monitoring periodontal diseases. , 2016, Periodontology 2000.

[25]  P. Gümüş,et al.  The Association Between Thalassemia Major and Periodontal Health. , 2015, Journal of periodontology.

[26]  Craig S. Miller,et al.  Targeted salivary biomarkers for discrimination of periodontal health and disease(s) , 2015, Front. Cell. Infect. Microbiol..

[27]  M. Cancro,et al.  The B Cell–Stimulatory Cytokines BLyS and APRIL Are Elevated in Human Periodontitis and Are Required for B Cell–Dependent Bone Loss in Experimental Murine Periodontitis , 2015, The Journal of Immunology.

[28]  I. Müller,et al.  Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages , 2014, Front. Immunol..

[29]  David F. Lappin,et al.  Saliva and serum levels of B-cell activating factors and tumor necrosis factor-α in patients with periodontitis. , 2014, Journal of periodontology.

[30]  G. Ramage,et al.  Comparison of circulating tumour necrosis factor superfamily cytokines in periodontitis patients undergoing supportive therapy: a case-controlled cross-sectional study comparing smokers and non-smokers in health and disease. , 2013, Journal of clinical periodontology.

[31]  L. Chyczewskî,et al.  High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis , 2013, Arthritis Research & Therapy.

[32]  A. Maisa,et al.  Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function , 2012, Aging cell.

[33]  G. Franco,et al.  Reduction of salivary arginine catabolic activity through periodontal therapy. , 2012, Quintessence international.

[34]  G. Hajishengallis.  Too old to fight? Aging and its toll on innate immunity. , 2010, Molecular oral microbiology.

[35]  V. Seyfert-Margolis,et al.  Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays , 2009, BMC Immunology.

[36]  P. Schneider,et al.  Cracking the BAFF code , 2009, Nature Reviews Immunology.

[37]  W. A. Saad,et al.  Smoking increases salivary arginase activity in patients with dental implants , 2009, Clinical Oral Investigations.

[38]  W. A. Saad,et al.  Periodontal therapy reduces arginase activity in saliva of patients with chronic periodontitis , 2008, Clinical Oral Investigations.

[39]  B. Aggarwal,et al.  A Previously Unrecognized Protein-Protein Interaction between TWEAK and CD163: Potential Biological Implications1 , 2007, The Journal of Immunology.

[40]  T. Matsuo,et al.  Proinflammatory effects of tumour necrosis factor‐like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts , 2006, Clinical and experimental immunology.

[41]  Stuart L. Segelnick,et al.  Reevaluation of initial therapy: when is the appropriate time? , 2006, Journal of periodontology.

[42]  J. Silke,et al.  TWEAK shall inherit the earth , 2006, Cell Death and Differentiation.

[43]  N. Deutz,et al.  Infected chronic wounds show different local and systemic arginine conversion compared with acute wounds. , 2006, The Journal of surgical research.

[44]  D. Kinane,et al.  Impact of smoking on the clinical, microbiological and immunological parameters of adult patients with periodontitis. , 2005, Journal of clinical periodontology.

[45]  J. Pers,et al.  Is periodontal disease mediated by salivary BAFF in Sjögren's syndrome? , 2005, Arthritis and rheumatism.

[46]  J. Pers,et al.  BAFF Overexpression Is Associated with Autoantibody Production in Autoimmune Diseases , 2005, Annals of the New York Academy of Sciences.

[47]  J. Cerhan,et al.  Epidemiologic Evaluation of Measurement Data in the Presence of Detection Limits , 2004, Environmental Health Perspectives.

[48]  C. Cobb.  Clinical significance of non-surgical periodontal therapy: an evidence-based perspective of scaling and root planing. , 2002, Journal of clinical periodontology.

[49]  S. Moestrup,et al.  Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma. , 2002, Blood.

[50]  Amy S Orr,et al.  BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. , 1999, Science.

[51]  K. Selvig,et al.  Early healing events at the dentin-connective tissue interface. Light and transmission electron microscopy observations. , 1991, Journal of periodontology.

[52]  M. Caldwell,et al.  Arginine metabolism in wounds. , 1988, The American journal of physiology.

[53]  J. Waerhaug.  Healing of the dento-epithelial junction following subgingival plaque control. I. As observed in human biopsy material. , 1978, Journal of periodontology.

[54]  F. Chinard.  Photometric estimation of proline and ornithine. , 1952, The Journal of biological chemistry.